公开(公告)号：US11789017B2

公开(公告)日：2023-10-17

申请号：US17119732

申请日：2020-12-11

Applicant: Magnolia Medical Technologies, Inc.

Inventor： Gregory J. Bullington ,  Jay M. Miazga ,  Shan E. Gaw ,  Paul Goldenbaum ,  Dylan Guelig

IPC: C12N15/10 ,  B01L3/00 ,  G01N21/3504 ,  G01N33/00 ,  G01N33/574 ,  G01N21/64 ,  A61K45/06 ,  G01N21/35 ,  G01N33/50 ,  G01N33/543 ,  B01L3/02 ,  G01N33/53

CPC classification number: G01N33/54388 ,  B01L3/0217 ,  B01L3/502715 ,  G01N33/5304 ,  B01L2300/0819 ,  B01L2400/0403

Abstract: A system includes a fluid transfer device and a lateral flow assay device. The fluid transfer device has an inlet fluidically coupleable to a bodily fluid source, an outlet fluidically coupleable to a sample reservoir, and a sequestration chamber configured to receive an initial volume of bodily fluid. The fluid transfer device can be transitioned between (1) a first state with the sequestration chamber in fluid communication with the inlet to receive the initial volume, (2) a second state with the outlet in fluid communication with the inlet to receive a subsequent flow of bodily fluid, and (3) a third state with the lateral flow assay device in fluid communication with the sequestration chamber to receive a portion of the initial volume of bodily fluid. The lateral flow assay device configured to provide an indication associated with a presence of a target analyte in the bodily fluid.

公开(公告)号：US12097027B2

公开(公告)日：2024-09-24

申请号：US15818173

申请日：2017-11-20

Applicant: Magnolia Medical Technologies, Inc.

Inventor： Gregory J. Bullington ,  Richard G. Patton ,  Shan E. Gaw ,  Jay M. Miazga ,  Jed McCann ,  Paul Goldenbaum

IPC: A61B5/15 ,  A61B5/153 ,  A61B5/154 ,  A61B5/155 ,  A61M5/162 ,  A61M5/178 ,  A61M5/48 ,  A61M39/02 ,  A61M39/22 ,  B01L3/00 ,  A61M5/32 ,  A61M25/00 ,  A61M25/06

CPC classification number: A61B5/150206 ,  A61B5/15003 ,  A61B5/150099 ,  A61B5/150221 ,  A61B5/150236 ,  A61B5/150244 ,  A61B5/150251 ,  A61B5/150351 ,  A61B5/150396 ,  A61B5/150519 ,  A61B5/150572 ,  A61B5/150732 ,  A61B5/15074 ,  A61B5/150946 ,  A61B5/153 ,  A61B5/154 ,  A61B5/155 ,  A61M5/162 ,  A61M5/178 ,  A61M5/48 ,  A61M39/0208 ,  A61M39/22 ,  B01L3/50825 ,  B01L3/563 ,  A61B5/150389 ,  A61M5/3286 ,  A61M25/005 ,  A61M25/065 ,  B01L2200/0689 ,  B01L2300/042 ,  B01L2300/044 ,  B01L2300/069 ,  B01L2300/0854 ,  B01L2400/0457 ,  B01L2400/0478 ,  B01L2400/049 ,  B01L2400/0616 ,  B01L2400/084

Abstract: A collection system configured to maintain the integrity of a bodily fluid sample has a proximal end portion, a distal end portion, and an inner surface defining a fluid flow path therethrough. The distal end portion is configured to be placed in fluid communication with a patient. The proximal end portion is configured to be placed in fluid communication with a fluid reservoir. The fluid flow path defined by the inner surface is associated with at least one flow characteristic configured to limit a stress within the flow of the bodily fluid between the distal end portion and the proximal end portion.

公开(公告)号：US20180140240A1

公开(公告)日：2018-05-24

申请号：US15818173

申请日：2017-11-20

Applicant: Magnolia Medical Technologies, Inc.

Inventor： Gregory J. Bullington ,  Richard G. Patton ,  Shan E. Gaw ,  Jay M. Miazga ,  Jed McCann ,  Paul Goldenbaum

IPC: A61B5/15

CPC classification number: A61B5/150206 ,  A61B5/15003 ,  A61B5/150099 ,  A61B5/150221 ,  A61B5/150236 ,  A61B5/150244 ,  A61B5/150251 ,  A61B5/150351 ,  A61B5/150389 ,  A61B5/150396 ,  A61B5/150519 ,  A61B5/150572 ,  A61B5/150732 ,  A61B5/15074 ,  A61B5/150946 ,  A61B5/153 ,  A61B5/154 ,  A61B5/155 ,  A61M5/162 ,  A61M5/178 ,  A61M5/3286 ,  A61M5/48 ,  A61M25/005 ,  A61M25/065 ,  A61M39/0208 ,  A61M39/22 ,  B01L3/50825 ,  B01L3/563 ,  B01L2200/0689 ,  B01L2300/042 ,  B01L2300/044 ,  B01L2300/069 ,  B01L2300/0854 ,  B01L2400/0457 ,  B01L2400/0478 ,  B01L2400/049 ,  B01L2400/0616 ,  B01L2400/084

Abstract: A collection system configured to maintain the integrity of a bodily fluid sample has a proximal end portion, a distal end portion, and an inner surface defining a fluid flow path therethrough. The distal end portion is configured to be placed in fluid communication with a patient. The proximal end portion is configured to be placed in fluid communication with a fluid reservoir. The fluid flow path defined by the inner surface is associated with at least one flow characteristic configured to limit a stress within the flow of the bodily fluid between the distal end portion and the proximal end portion.